Pub Date : 2024-12-01Epub Date: 2024-10-08DOI: 10.1002/ohn.1005
Rahul K Sharma, Montana Upton, Avi U Vaidya, Elizabeth S Longino, Feyisayo O Adegboye, Nicole G Desisto, Scott J Stephan, Shiayin F Yang, Priyesh N Patel
Objective: Reconstruction of skin cancer and Mohs micrographic surgery (MMS) defects of the head and neck is performed in both in-office and operating room (OR). This study intends to understand cost differences between reconstructive surgery for skin cancer defects in the OR and clinic to perform a cost-effectiveness analysis with single-institution patient satisfaction data.
Study design: Population-based retrospective analysis of cost data and an institutional, prospective survey of patient satisfaction.
Setting: National insurance database and institutional survey.
Methods: The Merative® MarketScan database was queried to identify claims involving the reconstruction of skin cancer defects of the head/neck between 2013 and 2020 for cost-analysis by setting (OR vs clinic). Patients undergoing operative and clinic-based reconstruction of MMS defects by 3 different surgeons at a single institution in 2023 were surveyed for satisfaction using a 5-point Likert scale. Data was coupled for cost-benefit analysis. Analysis was performed using propensity-matched samples.
Results: Using Marketscan, 1206 patients were analyzed for cost data. OR cases had a higher median baseline cost of $2308 (interquartile range [IQR]: 1484-3889) compared to procedures in the office (median $987, IQR: 784-1454, P < .001). Survey data from 116 patients revealed no significant difference in scores between OR and clinic cases (clinic: 4.57 vs OR: 4.60, P = .8752). Using propensity-matched subsets, providers incur an additional $4744 for a reduction in satisfaction of 0.083 when performing cases in the OR.
Conclusion: Lower cost is associated with reconstructive procedures performed in the office. This study is the first cost analysis of head and neck skin cancer reconstruction based on procedural settings and will be valuable to surgeons in considering practice patterns and resource utilization.
{"title":"Cost-Effectiveness Analysis of Operating Room and In-Office Reconstruction of Skin Cancer Defects.","authors":"Rahul K Sharma, Montana Upton, Avi U Vaidya, Elizabeth S Longino, Feyisayo O Adegboye, Nicole G Desisto, Scott J Stephan, Shiayin F Yang, Priyesh N Patel","doi":"10.1002/ohn.1005","DOIUrl":"10.1002/ohn.1005","url":null,"abstract":"<p><strong>Objective: </strong>Reconstruction of skin cancer and Mohs micrographic surgery (MMS) defects of the head and neck is performed in both in-office and operating room (OR). This study intends to understand cost differences between reconstructive surgery for skin cancer defects in the OR and clinic to perform a cost-effectiveness analysis with single-institution patient satisfaction data.</p><p><strong>Study design: </strong>Population-based retrospective analysis of cost data and an institutional, prospective survey of patient satisfaction.</p><p><strong>Setting: </strong>National insurance database and institutional survey.</p><p><strong>Methods: </strong>The Merative® MarketScan database was queried to identify claims involving the reconstruction of skin cancer defects of the head/neck between 2013 and 2020 for cost-analysis by setting (OR vs clinic). Patients undergoing operative and clinic-based reconstruction of MMS defects by 3 different surgeons at a single institution in 2023 were surveyed for satisfaction using a 5-point Likert scale. Data was coupled for cost-benefit analysis. Analysis was performed using propensity-matched samples.</p><p><strong>Results: </strong>Using Marketscan, 1206 patients were analyzed for cost data. OR cases had a higher median baseline cost of $2308 (interquartile range [IQR]: 1484-3889) compared to procedures in the office (median $987, IQR: 784-1454, P < .001). Survey data from 116 patients revealed no significant difference in scores between OR and clinic cases (clinic: 4.57 vs OR: 4.60, P = .8752). Using propensity-matched subsets, providers incur an additional $4744 for a reduction in satisfaction of 0.083 when performing cases in the OR.</p><p><strong>Conclusion: </strong>Lower cost is associated with reconstructive procedures performed in the office. This study is the first cost analysis of head and neck skin cancer reconstruction based on procedural settings and will be valuable to surgeons in considering practice patterns and resource utilization.</p>","PeriodicalId":19707,"journal":{"name":"Otolaryngology- Head and Neck Surgery","volume":" ","pages":"1715-1720"},"PeriodicalIF":2.6,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142392293","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-01Epub Date: 2024-07-17DOI: 10.1002/ohn.909
Kathryn Wie, Shalini Shah, Paul Allen, Michael Castle, Margo McKenna, John Faria
Objectives: Ear tube removal and patch myringoplasty are frequently performed. The indication and timing for surgery varies among otolaryngologists. This study identifies risk factors associated with the need for the replacement of tympanostomy tubes after tube removal and myringoplasty.
Study design: Case series with chart review.
Setting: Single institution academic otolaryngology practice.
Methods: Patients younger than 12 years of age who underwent tympanostomy tube removal and myringoplasty at the University of Rochester Medical Center from March 2011 to September 2019. Patients with tympanostomy tube removal due to chronic otorrhea were excluded.
Results: One hundred sixty-one patients (230 ears) met inclusion criteria and had sufficient follow-up. Myringoplasty success after tube removal was 94.8%. Successful myringoplasty was associated with shorter tube duration (32 months) versus unsuccessful myringoplasty (40 months) (P = .02). Replacement tympanostomy tubes after myringoplasty occurred in 9.6% of ears. There was no difference in average patient age (P = .96) or duration of tubes (P = .74) in patients who required replacement of tympanostomy tubes versus patients who did not require tube replacement. Patients with a cleft abnormality were more likely to require tympanostomy tube replacement (P < .001).
Conclusions: Most children do not need tubes replaced after removal. This study identified cleft abnormality as a factor that increased the need for replacement tubes. Longer tube durations of over 3 years negatively impacted myringoplasty success. Tympanostomy tube removal should be considered 2 to 3 years after placement in most patients with longer tube durations considered in children with a repaired cleft palate.
{"title":"Risk Factors for Replacement of Tympanostomy Tubes After Surgical Removal for Pediatric Patients.","authors":"Kathryn Wie, Shalini Shah, Paul Allen, Michael Castle, Margo McKenna, John Faria","doi":"10.1002/ohn.909","DOIUrl":"10.1002/ohn.909","url":null,"abstract":"<p><strong>Objectives: </strong>Ear tube removal and patch myringoplasty are frequently performed. The indication and timing for surgery varies among otolaryngologists. This study identifies risk factors associated with the need for the replacement of tympanostomy tubes after tube removal and myringoplasty.</p><p><strong>Study design: </strong>Case series with chart review.</p><p><strong>Setting: </strong>Single institution academic otolaryngology practice.</p><p><strong>Methods: </strong>Patients younger than 12 years of age who underwent tympanostomy tube removal and myringoplasty at the University of Rochester Medical Center from March 2011 to September 2019. Patients with tympanostomy tube removal due to chronic otorrhea were excluded.</p><p><strong>Results: </strong>One hundred sixty-one patients (230 ears) met inclusion criteria and had sufficient follow-up. Myringoplasty success after tube removal was 94.8%. Successful myringoplasty was associated with shorter tube duration (32 months) versus unsuccessful myringoplasty (40 months) (P = .02). Replacement tympanostomy tubes after myringoplasty occurred in 9.6% of ears. There was no difference in average patient age (P = .96) or duration of tubes (P = .74) in patients who required replacement of tympanostomy tubes versus patients who did not require tube replacement. Patients with a cleft abnormality were more likely to require tympanostomy tube replacement (P < .001).</p><p><strong>Conclusions: </strong>Most children do not need tubes replaced after removal. This study identified cleft abnormality as a factor that increased the need for replacement tubes. Longer tube durations of over 3 years negatively impacted myringoplasty success. Tympanostomy tube removal should be considered 2 to 3 years after placement in most patients with longer tube durations considered in children with a repaired cleft palate.</p>","PeriodicalId":19707,"journal":{"name":"Otolaryngology- Head and Neck Surgery","volume":" ","pages":"1859-1865"},"PeriodicalIF":2.6,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141627293","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-01Epub Date: 2024-08-02DOI: 10.1002/ohn.925
Tyler Howard, Abbigayle Willgruber, Brian Kinealy, David Adkins, Raleigh Jones, Matthew Bush
Objective: This cross-sectional website analysis aimed to determine the readability and quality of English and Spanish websites pertaining to the prevention of noise-induced hearing loss.
Study design: Cross-sectional website analysis.
Setting: Various online search engines.
Methods: We queried four popular search engines using the term "noise-induced hearing loss prevention" to reveal the top 50 English and top 50 Spanish websites for data collection. Websites meeting inclusion criteria were stratified based on the presence of a Health on the Net Code certificate (independent assessment of honesty, reliability, and quality). Websites were then independently reviewed by experts using the DISCERN criteria in order to assess information quality. Readability was calculated using the Flesch reading ease score for English and the Fernandez-Huerta formula for Spanish websites.
Results: Thirty-six English websites and 32 Spanish websites met the inclusion criteria. English websites had significantly lower readability (average = 56.34, SD = 11.17) compared to Spanish websites (average = 61.88, SD = 5.33) (P < .05). Spanish websites (average = 37, SD = 8.47) were also of significantly higher quality than English websites (average = 25.13, SD = 10.11).
Conclusion: This study emphasizes the importance of providing quality and readable materials to patients seeking information about noise-induced hearing loss prevention. All of the English and Spanish websites reviewed were written at a level higher than the American Medical Association-recommended sixth-grade reading level. The study also highlights the need for evidence-based information online provided by experts in our field.
研究目的这项横断面网站分析旨在确定与预防噪声性听力损失相关的英文和西班牙文网站的可读性和质量:研究设计:横断面网站分析:环境:各种在线搜索引擎:我们使用 "噪声引起的听力损失预防 "这一术语查询了四个常用搜索引擎,从而找出了排名前 50 位的英文网站和排名前 50 位的西班牙文网站,以便收集数据。符合纳入标准的网站根据是否有 Health on the Net Code 证书(对诚实、可靠性和质量的独立评估)进行分层。然后由专家使用 DISCERN 标准对网站进行独立审查,以评估信息质量。英文网站的可读性采用弗莱什易读性评分法计算,西班牙文网站的可读性采用费尔南德斯-胡埃塔公式计算:结果:36 个英文网站和 32 个西班牙文网站符合纳入标准。与西班牙文网站(平均 = 61.88,SD = 5.33)相比,英文网站的可读性明显较低(平均 = 56.34,SD = 11.17)(P 结论:本研究强调了为寻求噪声性听力损失预防信息的患者提供高质量和可读性材料的重要性。所有被审查的英文和西班牙文网站的文字水平都高于美国医学会推荐的六年级阅读水平。这项研究还强调了由本领域专家提供基于证据的在线信息的必要性。
{"title":"Quality and Readability of Noise-Induced Hearing Loss Prevention-Related Websites.","authors":"Tyler Howard, Abbigayle Willgruber, Brian Kinealy, David Adkins, Raleigh Jones, Matthew Bush","doi":"10.1002/ohn.925","DOIUrl":"10.1002/ohn.925","url":null,"abstract":"<p><strong>Objective: </strong>This cross-sectional website analysis aimed to determine the readability and quality of English and Spanish websites pertaining to the prevention of noise-induced hearing loss.</p><p><strong>Study design: </strong>Cross-sectional website analysis.</p><p><strong>Setting: </strong>Various online search engines.</p><p><strong>Methods: </strong>We queried four popular search engines using the term \"noise-induced hearing loss prevention\" to reveal the top 50 English and top 50 Spanish websites for data collection. Websites meeting inclusion criteria were stratified based on the presence of a Health on the Net Code certificate (independent assessment of honesty, reliability, and quality). Websites were then independently reviewed by experts using the DISCERN criteria in order to assess information quality. Readability was calculated using the Flesch reading ease score for English and the Fernandez-Huerta formula for Spanish websites.</p><p><strong>Results: </strong>Thirty-six English websites and 32 Spanish websites met the inclusion criteria. English websites had significantly lower readability (average = 56.34, SD = 11.17) compared to Spanish websites (average = 61.88, SD = 5.33) (P < .05). Spanish websites (average = 37, SD = 8.47) were also of significantly higher quality than English websites (average = 25.13, SD = 10.11).</p><p><strong>Conclusion: </strong>This study emphasizes the importance of providing quality and readable materials to patients seeking information about noise-induced hearing loss prevention. All of the English and Spanish websites reviewed were written at a level higher than the American Medical Association-recommended sixth-grade reading level. The study also highlights the need for evidence-based information online provided by experts in our field.</p>","PeriodicalId":19707,"journal":{"name":"Otolaryngology- Head and Neck Surgery","volume":" ","pages":"1758-1763"},"PeriodicalIF":2.6,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141875515","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-01Epub Date: 2024-07-11DOI: 10.1002/ohn.895
Anselm Joseph Gadenstaetter, Paul Emmerich Krumpoeck, Alice Barbara Auinger, Erdem Yildiz, Aldine Tu, Christian Matula, Christoph Arnoldner, Lukas David Landegger
Objective: Determining the concentration of prestin in human blood, cerebrospinal fluid (CSF), and perilymph (PL), and evaluating its suitability as a clinical biomarker for sensori-neural hearing loss (SNHL).
Study design: Human blood, CSF, and PL samples were intraoperatively collected from 42 patients with tumors of the internal auditory canal or with intracochlear tumors undergoing translabyrinthine or middle fossa tumor removal. Prestin concentration was measured using enzyme-linked immunosorbent assay and linear regression analyses were performed to investigate its associations with audiological as well as vestibular test results.
Setting: Tertiary referral center.
Results: The median prestin concentration in blood samples of the 42 study participants (26 women, mean ± standard deviation age, 52.7 ± 12.5 years) was 1.32 (interquartile range, IQR, 0.71-1.99) ng/mL. CSF prestin levels were significantly higher with 4.73 (IQR, 2.45-14.03) ng/mL (P = .005). With 84.74 (IQR, 38.95-122.00) ng/mL, PL prestin concentration was significantly higher compared to blood (P = .01) and CSF (P = .03) levels. Linear regression analyses showed significant associations of CSF prestin concentration with preoperative hearing levels (pure-tone average and word recognition; P = .008, R2 = 0.1894; P = .03, R2 = 0.1857), but no correlations with blood or PL levels.
Conclusion and relevance: This study's findings highlight the volatile nature of prestin levels and provide the first insights into this potential biomarker's concentrations in body fluids apart from blood. Future investigations should comprehensively assess human prestin levels with different etiologies of SNHL, prestin's natural homeostasis and systemic circulation, and its temporal dynamics after cochlear trauma. Finally, clinically approved detection kits for prestin are urgently required prior to considering a potential translational implementation of this diagnostic technique.
{"title":"Prestin in Human Perilymph, Cerebrospinal Fluid, and Blood as a Biomarker for Hearing Loss.","authors":"Anselm Joseph Gadenstaetter, Paul Emmerich Krumpoeck, Alice Barbara Auinger, Erdem Yildiz, Aldine Tu, Christian Matula, Christoph Arnoldner, Lukas David Landegger","doi":"10.1002/ohn.895","DOIUrl":"10.1002/ohn.895","url":null,"abstract":"<p><strong>Objective: </strong>Determining the concentration of prestin in human blood, cerebrospinal fluid (CSF), and perilymph (PL), and evaluating its suitability as a clinical biomarker for sensori-neural hearing loss (SNHL).</p><p><strong>Study design: </strong>Human blood, CSF, and PL samples were intraoperatively collected from 42 patients with tumors of the internal auditory canal or with intracochlear tumors undergoing translabyrinthine or middle fossa tumor removal. Prestin concentration was measured using enzyme-linked immunosorbent assay and linear regression analyses were performed to investigate its associations with audiological as well as vestibular test results.</p><p><strong>Setting: </strong>Tertiary referral center.</p><p><strong>Results: </strong>The median prestin concentration in blood samples of the 42 study participants (26 women, mean ± standard deviation age, 52.7 ± 12.5 years) was 1.32 (interquartile range, IQR, 0.71-1.99) ng/mL. CSF prestin levels were significantly higher with 4.73 (IQR, 2.45-14.03) ng/mL (P = .005). With 84.74 (IQR, 38.95-122.00) ng/mL, PL prestin concentration was significantly higher compared to blood (P = .01) and CSF (P = .03) levels. Linear regression analyses showed significant associations of CSF prestin concentration with preoperative hearing levels (pure-tone average and word recognition; P = .008, R<sup>2</sup> = 0.1894; P = .03, R<sup>2</sup> = 0.1857), but no correlations with blood or PL levels.</p><p><strong>Conclusion and relevance: </strong>This study's findings highlight the volatile nature of prestin levels and provide the first insights into this potential biomarker's concentrations in body fluids apart from blood. Future investigations should comprehensively assess human prestin levels with different etiologies of SNHL, prestin's natural homeostasis and systemic circulation, and its temporal dynamics after cochlear trauma. Finally, clinically approved detection kits for prestin are urgently required prior to considering a potential translational implementation of this diagnostic technique.</p>","PeriodicalId":19707,"journal":{"name":"Otolaryngology- Head and Neck Surgery","volume":" ","pages":"1825-1833"},"PeriodicalIF":2.6,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11605028/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141580496","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-01Epub Date: 2024-10-16DOI: 10.1002/ohn.1022
Nathaniel Hunter, Aidan Wright, Vivian Jin, Andrew Tritter
Objective: No studies describe what patients search for online in relation to retrograde cricopharyngeal dysfunction (RCPD). Our objectives were to describe the Google search volume for RCPD, identify the most common queries related to RCPD, and evaluate the available online resources.
Study design: Observational.
Setting: Google Database.
Methods: Using Ahrefs and Search Response, Google search volume for RCPD and "People Also Ask" (PAA) questions were documented. PAA questions were categorized based on intent, and the websites were categorized on source. The quality and readability of the sources were determined using the Journal of the American Medical Association (JAMA) benchmark criteria, Flesch Reading Ease score, and Flesch-Kincaid Grade Level.
Results: Search volume for RCPD-related content has continually increased since 2021, with a combined average volume of 6287 searches per month. Most PAA questions were related to technical details (61.07%) and treatments (32.06%) for RCPD. Websites provided to answer these questions were most often from academic (25.95%) and commercial (22.14%) sources. None of the sources met the criteria for universal readability, and only 15% met all quality metrics set forth by JAMA.
Conclusion: Interest in RCPD is at an all-time high, with information related to its diagnosis and treatment most popular among Google users. Significantly, none of the resources provided by Google met the criteria for universal readability, preventing many patients from fully comprehending the information presented. Future work should aim to address questions related to RCPD in a suitable way for all patient demographics.
{"title":"Retrograde Cricopharyngeal Dysfunction: A Google Search Analysis.","authors":"Nathaniel Hunter, Aidan Wright, Vivian Jin, Andrew Tritter","doi":"10.1002/ohn.1022","DOIUrl":"10.1002/ohn.1022","url":null,"abstract":"<p><strong>Objective: </strong>No studies describe what patients search for online in relation to retrograde cricopharyngeal dysfunction (RCPD). Our objectives were to describe the Google search volume for RCPD, identify the most common queries related to RCPD, and evaluate the available online resources.</p><p><strong>Study design: </strong>Observational.</p><p><strong>Setting: </strong>Google Database.</p><p><strong>Methods: </strong>Using Ahrefs and Search Response, Google search volume for RCPD and \"People Also Ask\" (PAA) questions were documented. PAA questions were categorized based on intent, and the websites were categorized on source. The quality and readability of the sources were determined using the Journal of the American Medical Association (JAMA) benchmark criteria, Flesch Reading Ease score, and Flesch-Kincaid Grade Level.</p><p><strong>Results: </strong>Search volume for RCPD-related content has continually increased since 2021, with a combined average volume of 6287 searches per month. Most PAA questions were related to technical details (61.07%) and treatments (32.06%) for RCPD. Websites provided to answer these questions were most often from academic (25.95%) and commercial (22.14%) sources. None of the sources met the criteria for universal readability, and only 15% met all quality metrics set forth by JAMA.</p><p><strong>Conclusion: </strong>Interest in RCPD is at an all-time high, with information related to its diagnosis and treatment most popular among Google users. Significantly, none of the resources provided by Google met the criteria for universal readability, preventing many patients from fully comprehending the information presented. Future work should aim to address questions related to RCPD in a suitable way for all patient demographics.</p>","PeriodicalId":19707,"journal":{"name":"Otolaryngology- Head and Neck Surgery","volume":" ","pages":"1808-1815"},"PeriodicalIF":2.6,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142471820","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-01Epub Date: 2024-08-09DOI: 10.1002/ohn.933
Nupur Bhatt, Jackie Yang, Lauren DeBaere, Ronald Shen Wang, Allison Most, Yan Zhang, Elan Dayanov, Wenqing Yang, Michele Santacatterina, Maria Kamberi, Jacqueline Mojica, Emily Kamen, Justin Savitski, John Stein, Adam Jacobson
Objective: To investigate whether a new preoperative education and discharge planning protocol reduced unexpected discharge delays for patients undergoing reconstructive surgery for head and neck cancer.
Methods: A quality improvement (QI) intervention was implemented in January 2021 with several components to address historically prolonged observed lengths of stay (LOS) with head and neck cancer patients. The intervention added a preoperative educational visit with a head and neck cancer advanced practice provider, a standardized preoperative speech and swallow assessment, a personalized patient care plan document, discussion of inpatient hospital stay expectations, and early discharge planning. The intervention group included patients who underwent the preoperative education protocol from February to December 2021. For comparison, an age and sex-matched control group was constructed from inpatients who had been admitted for similar procedures in the 2 years prior to the QI intervention (2019-2020) and received standard of care counseling.
Results: Our study demonstrated a significant reduction in observed to expected LOS ratio after implementation of the intervention (1.24 ± 0.74 control, 0.95 ± 0.52 intervention; P = .012).
Discussion: We discuss a preoperative education QI intervention at our institution. Our findings demonstrate that our intervention was associated with decreased LOS for patients undergoing head and neck reconstructive surgeries.
Implications for practice: This QI study shows the benefit of a new standardized preoperative education and discharge planning protocol for patients undergoing head and neck reconstructive surgeries.
{"title":"Reducing Length of Stay in Reconstructive Head and Neck Surgery Patients: A Quality Improvement Initiative.","authors":"Nupur Bhatt, Jackie Yang, Lauren DeBaere, Ronald Shen Wang, Allison Most, Yan Zhang, Elan Dayanov, Wenqing Yang, Michele Santacatterina, Maria Kamberi, Jacqueline Mojica, Emily Kamen, Justin Savitski, John Stein, Adam Jacobson","doi":"10.1002/ohn.933","DOIUrl":"10.1002/ohn.933","url":null,"abstract":"<p><strong>Objective: </strong>To investigate whether a new preoperative education and discharge planning protocol reduced unexpected discharge delays for patients undergoing reconstructive surgery for head and neck cancer.</p><p><strong>Methods: </strong>A quality improvement (QI) intervention was implemented in January 2021 with several components to address historically prolonged observed lengths of stay (LOS) with head and neck cancer patients. The intervention added a preoperative educational visit with a head and neck cancer advanced practice provider, a standardized preoperative speech and swallow assessment, a personalized patient care plan document, discussion of inpatient hospital stay expectations, and early discharge planning. The intervention group included patients who underwent the preoperative education protocol from February to December 2021. For comparison, an age and sex-matched control group was constructed from inpatients who had been admitted for similar procedures in the 2 years prior to the QI intervention (2019-2020) and received standard of care counseling.</p><p><strong>Results: </strong>Our study demonstrated a significant reduction in observed to expected LOS ratio after implementation of the intervention (1.24 ± 0.74 control, 0.95 ± 0.52 intervention; P = .012).</p><p><strong>Discussion: </strong>We discuss a preoperative education QI intervention at our institution. Our findings demonstrate that our intervention was associated with decreased LOS for patients undergoing head and neck reconstructive surgeries.</p><p><strong>Implications for practice: </strong>This QI study shows the benefit of a new standardized preoperative education and discharge planning protocol for patients undergoing head and neck reconstructive surgeries.</p>","PeriodicalId":19707,"journal":{"name":"Otolaryngology- Head and Neck Surgery","volume":" ","pages":"1938-1948"},"PeriodicalIF":2.6,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141907332","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-01Epub Date: 2024-08-27DOI: 10.1002/ohn.952
Tyler J Gallagher, Jason Chwa, Matthew E Lin, Niels C Kokot
Objective: To examine prevalence of partial and complete HPV vaccination among middle-aged adults and factors associated with vaccination status.
Study design: Nationally representative cross-sectional survey.
Setting: United States.
Methods: Cohort includes adults aged 30 to 44 years from 2018 to 2022 Behavioral Risk Factor Surveillance System (BRFSS) survey who completed questions about HPV vaccination status. Survey-weighted multivariable logistic regression was utilized to explore factors associated with partial and complete HPV vaccination status.
Results: In this nationally representative cohort of 26,470 US middle-aged adults, 15.8% [95% confidence interval [CI]: 15.1%-16.6%] reported any HPV vaccination, and 6.5% [95% CI: 6.0%-7.0%] reported complete HPV vaccination. On multivariable regression, younger age, female sex, residence in the West or Northeast, higher educational attainment, unmarried status, having a personal healthcare provider, and gay or lesbian sexual orientation were associated with increased likelihood of vaccination. Race was variably associated with vaccination status. Annual income, insurance status, cancer history, head and neck cancer history, and time of last physician checkup were not associated with HPV vaccination status.
Conclusion: HPV vaccination among middle-aged adults who were not previously vaccinated should be based on risk for new HPV infection and possible benefits of vaccination. While our analysis shows that consideration of personal factors likely plays a role in HPV vaccination in this cohort, we also find that gaps in vaccination may exist due to other socioeconomic disparities between sexes, educational attainment levels, racial/ethnic groups, geographic regions, and access to a personal healthcare provider. These factors' influence suggests potential room for improved public health measures.
{"title":"Factors Associated with HPV Vaccination Among Middle-Aged Adults in the United States.","authors":"Tyler J Gallagher, Jason Chwa, Matthew E Lin, Niels C Kokot","doi":"10.1002/ohn.952","DOIUrl":"10.1002/ohn.952","url":null,"abstract":"<p><strong>Objective: </strong>To examine prevalence of partial and complete HPV vaccination among middle-aged adults and factors associated with vaccination status.</p><p><strong>Study design: </strong>Nationally representative cross-sectional survey.</p><p><strong>Setting: </strong>United States.</p><p><strong>Methods: </strong>Cohort includes adults aged 30 to 44 years from 2018 to 2022 Behavioral Risk Factor Surveillance System (BRFSS) survey who completed questions about HPV vaccination status. Survey-weighted multivariable logistic regression was utilized to explore factors associated with partial and complete HPV vaccination status.</p><p><strong>Results: </strong>In this nationally representative cohort of 26,470 US middle-aged adults, 15.8% [95% confidence interval [CI]: 15.1%-16.6%] reported any HPV vaccination, and 6.5% [95% CI: 6.0%-7.0%] reported complete HPV vaccination. On multivariable regression, younger age, female sex, residence in the West or Northeast, higher educational attainment, unmarried status, having a personal healthcare provider, and gay or lesbian sexual orientation were associated with increased likelihood of vaccination. Race was variably associated with vaccination status. Annual income, insurance status, cancer history, head and neck cancer history, and time of last physician checkup were not associated with HPV vaccination status.</p><p><strong>Conclusion: </strong>HPV vaccination among middle-aged adults who were not previously vaccinated should be based on risk for new HPV infection and possible benefits of vaccination. While our analysis shows that consideration of personal factors likely plays a role in HPV vaccination in this cohort, we also find that gaps in vaccination may exist due to other socioeconomic disparities between sexes, educational attainment levels, racial/ethnic groups, geographic regions, and access to a personal healthcare provider. These factors' influence suggests potential room for improved public health measures.</p>","PeriodicalId":19707,"journal":{"name":"Otolaryngology- Head and Neck Surgery","volume":" ","pages":"1780-1791"},"PeriodicalIF":2.6,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142073509","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-01Epub Date: 2024-07-06DOI: 10.1002/ohn.892
Raewyn G Campbell, Joshua R Zadro, Andrew R Gamble, Cliffton L Chan, Martin G Mackey, Gabriel Osie, Lu Hui Png, Richard G Douglas, Evangelos Pappas
Objective: Endoscopic sinus and skull base surgery has led to significant improvements in patient outcomes, yet may have come at a cost to surgeons' musculoskeletal (MSK) health. We aimed to determine the prevalence and characteristics of work-related MSK disorders (WRMDs) in endoscopic sinus and skull base surgeons; to investigate contributing factors for WRMD in this population; and to evaluate the effectiveness of ergonomic interventions on the severity or prevalence of WRMD in this population.
Data sources: Medline, Embase, CINAHL, Web of Science, and Scopus from inception to April 2, 2024. A bibliographic examination was performed for further papers.
Review methods: Inclusion criteria included original peer-reviewed papers with work-related MSK outcomes (prevalence, contributing factors, and interventions) relating to endoscopic sinus and/or skull base surgeons in any language.
Results: Of 25,772 unique citations, 37 studies met the inclusion criteria. The pooled lifetime, point, and 12-month prevalences of WRMD were 75.9% (95% confidence interval; I2, 67.2%-83.6%, I2 95.6%), 80.8% (77.0%-84.3%, I2 98.0%), and 82.0% (71.8%-90.3%, I2 60.96%) respectively. The neck, lumbar spine, and thoracic spine were the most commonly involved areas. One of 9 studies on contributing factors investigated discomfort as an outcome. The remainder focussed on surrogate outcomes (eg, posture, hand dysfunction). Two of the 13 intervention studies investigated pain or fatigue as an outcome. The remainder targeted posture, muscle activity, or workload.
Conclusion: WRMDs are highly prevalent in endoscopic sinus and skull base surgeons. Further studies focusing on the direct outcomes of WRMD such as pain are needed.
{"title":"Work-Related Musculoskeletal Disorders in Endoscopic Sinus and Skull Base Surgery: A Systematic Review With Meta-analysis.","authors":"Raewyn G Campbell, Joshua R Zadro, Andrew R Gamble, Cliffton L Chan, Martin G Mackey, Gabriel Osie, Lu Hui Png, Richard G Douglas, Evangelos Pappas","doi":"10.1002/ohn.892","DOIUrl":"10.1002/ohn.892","url":null,"abstract":"<p><strong>Objective: </strong>Endoscopic sinus and skull base surgery has led to significant improvements in patient outcomes, yet may have come at a cost to surgeons' musculoskeletal (MSK) health. We aimed to determine the prevalence and characteristics of work-related MSK disorders (WRMDs) in endoscopic sinus and skull base surgeons; to investigate contributing factors for WRMD in this population; and to evaluate the effectiveness of ergonomic interventions on the severity or prevalence of WRMD in this population.</p><p><strong>Data sources: </strong>Medline, Embase, CINAHL, Web of Science, and Scopus from inception to April 2, 2024. A bibliographic examination was performed for further papers.</p><p><strong>Review methods: </strong>Inclusion criteria included original peer-reviewed papers with work-related MSK outcomes (prevalence, contributing factors, and interventions) relating to endoscopic sinus and/or skull base surgeons in any language.</p><p><strong>Results: </strong>Of 25,772 unique citations, 37 studies met the inclusion criteria. The pooled lifetime, point, and 12-month prevalences of WRMD were 75.9% (95% confidence interval; I<sup>2</sup>, 67.2%-83.6%, I<sup>2</sup> 95.6%), 80.8% (77.0%-84.3%, I<sup>2</sup> 98.0%), and 82.0% (71.8%-90.3%, I<sup>2</sup> 60.96%) respectively. The neck, lumbar spine, and thoracic spine were the most commonly involved areas. One of 9 studies on contributing factors investigated discomfort as an outcome. The remainder focussed on surrogate outcomes (eg, posture, hand dysfunction). Two of the 13 intervention studies investigated pain or fatigue as an outcome. The remainder targeted posture, muscle activity, or workload.</p><p><strong>Conclusion: </strong>WRMDs are highly prevalent in endoscopic sinus and skull base surgeons. Further studies focusing on the direct outcomes of WRMD such as pain are needed.</p>","PeriodicalId":19707,"journal":{"name":"Otolaryngology- Head and Neck Surgery","volume":" ","pages":"1650-1669"},"PeriodicalIF":2.6,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11605027/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141545133","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-01Epub Date: 2024-07-30DOI: 10.1002/ohn.919
Matthew Nguyen, Ameen Amanian, Meihan Wei, Eitan Prisman, Pedro Alejandro Mendez-Tellez
Objective: It is difficult to predict which mechanically ventilated patients will ultimately require a tracheostomy which further predisposes them to unnecessary spontaneous breathing trials, additional time on the ventilator, increased costs, and further ventilation-related complications such as subglottic stenosis. In this study, we aimed to develop a machine learning tool to predict which patients need a tracheostomy at the onset of admission to the intensive care unit (ICU).
Study design: Retrospective Cohort Study.
Setting: Multicenter Study of 335 Intensive Care Units between 2014 and 2015.
Methods: The eICU Collaborative Research Database (eICU-CRD) was utilized to obtain the patient cohort. Inclusion criteria included: (1) Age >18 years and (2) ICU admission requiring mechanical ventilation. The primary outcome of interest included tracheostomy assessed via a binary classification model. Models included logistic regression (LR), random forest (RF), and Extreme Gradient Boosting (XGBoost).
Results: Of 38,508 invasively mechanically ventilated patients, 1605 patients underwent a tracheostomy. The XGBoost, RF, and LR models had fair performances at an AUROC 0.794, 0.780, and 0.775 respectively. Limiting the XGBoost model to 20 features out of 331, a minimal reduction in performance was observed with an AUROC of 0.778. Using Shapley Additive Explanations, the top features were an admission diagnosis of pneumonia or sepsis and comorbidity of chronic respiratory failure.
Conclusions: Our machine learning model accurately predicts the probability that a patient will eventually require a tracheostomy upon ICU admission, and upon prospective validation, we have the potential to institute earlier interventions and reduce the complications of prolonged ventilation.
{"title":"Predicting Tracheostomy Need on Admission to the Intensive Care Unit-A Multicenter Machine Learning Analysis.","authors":"Matthew Nguyen, Ameen Amanian, Meihan Wei, Eitan Prisman, Pedro Alejandro Mendez-Tellez","doi":"10.1002/ohn.919","DOIUrl":"10.1002/ohn.919","url":null,"abstract":"<p><strong>Objective: </strong>It is difficult to predict which mechanically ventilated patients will ultimately require a tracheostomy which further predisposes them to unnecessary spontaneous breathing trials, additional time on the ventilator, increased costs, and further ventilation-related complications such as subglottic stenosis. In this study, we aimed to develop a machine learning tool to predict which patients need a tracheostomy at the onset of admission to the intensive care unit (ICU).</p><p><strong>Study design: </strong>Retrospective Cohort Study.</p><p><strong>Setting: </strong>Multicenter Study of 335 Intensive Care Units between 2014 and 2015.</p><p><strong>Methods: </strong>The eICU Collaborative Research Database (eICU-CRD) was utilized to obtain the patient cohort. Inclusion criteria included: (1) Age >18 years and (2) ICU admission requiring mechanical ventilation. The primary outcome of interest included tracheostomy assessed via a binary classification model. Models included logistic regression (LR), random forest (RF), and Extreme Gradient Boosting (XGBoost).</p><p><strong>Results: </strong>Of 38,508 invasively mechanically ventilated patients, 1605 patients underwent a tracheostomy. The XGBoost, RF, and LR models had fair performances at an AUROC 0.794, 0.780, and 0.775 respectively. Limiting the XGBoost model to 20 features out of 331, a minimal reduction in performance was observed with an AUROC of 0.778. Using Shapley Additive Explanations, the top features were an admission diagnosis of pneumonia or sepsis and comorbidity of chronic respiratory failure.</p><p><strong>Conclusions: </strong>Our machine learning model accurately predicts the probability that a patient will eventually require a tracheostomy upon ICU admission, and upon prospective validation, we have the potential to institute earlier interventions and reduce the complications of prolonged ventilation.</p>","PeriodicalId":19707,"journal":{"name":"Otolaryngology- Head and Neck Surgery","volume":" ","pages":"1736-1750"},"PeriodicalIF":2.6,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11605030/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141793037","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-01Epub Date: 2024-08-27DOI: 10.1002/ohn.957
Giancarlo Tirelli, Nicoletta Gardenal, Jerry Polesel, Jasmina De Groodt, Erik Radin, Fabiola Giudici, Laura Iandolo, Simone Zucchini, Egidio Sia, Paolo Boscolo-Rizzo
Objective: The present study challenges the appropriateness of considering invasion of the palatoglossus muscle (PGM) as a criterion for staging oropharyngeal squamous cell carcinoma (OPSCC) as T4.
Study design: Retrospective observational study.
Setting: Tertiary University Hospital.
Methods: This retrospective study included nonmetastatic OPSCC patients treated with curative intent at the University of Trieste, Italy from 2015 to 2021. Patients were categorized into 4 groups: (1) tumors classified as T1-T2 by both International Cancer Control (UICC) and American Joint Committee on Cancer (AJCC)-TNM; (2) T1-T2 tumors upgraded to T4 solely by UICC due to oropharyngeal PGM infiltration; (3) T1-T2 tumors upgraded to T4 by both UICC and AJCC due to oral PGM infiltration; (4) tumors classified as T3-T4 by both UICC and AJCC. Kaplan-Meier analysis estimated overall survival (OS) and disease-free survival (DFS). Multivariable Cox models, adjusted for clinical factors, assessed the impact of palatoglossus invasion on outcomes over 5 years.
Results: A total of 121 consecutive patients with primary OPSCC were included (median [interquartile range] age 65 years [58-74]; 63% male). While patients with upgraded T4 category due to infiltration of the oral portion of the PGM exhibited a prognosis superimposable on that of other patients with advanced stage disease, those with upgraded T4 category due to infiltration of the oropharyngeal portion of the PGM displayed OS and DFS comparable to T1-T2 patients.
Conclusion: Our findings highlight that invasion of the oropharyngeal portion of the PGM may not be a suitable criterion for staging OPSCC as T4. Further research involving larger and independent patient cohorts is strongly encouraged to corroborate these observations.
{"title":"Palatoglossus Muscle and T4 Category in the Eighth Edition of TNM Staging System for OPSCC.","authors":"Giancarlo Tirelli, Nicoletta Gardenal, Jerry Polesel, Jasmina De Groodt, Erik Radin, Fabiola Giudici, Laura Iandolo, Simone Zucchini, Egidio Sia, Paolo Boscolo-Rizzo","doi":"10.1002/ohn.957","DOIUrl":"10.1002/ohn.957","url":null,"abstract":"<p><strong>Objective: </strong>The present study challenges the appropriateness of considering invasion of the palatoglossus muscle (PGM) as a criterion for staging oropharyngeal squamous cell carcinoma (OPSCC) as T4.</p><p><strong>Study design: </strong>Retrospective observational study.</p><p><strong>Setting: </strong>Tertiary University Hospital.</p><p><strong>Methods: </strong>This retrospective study included nonmetastatic OPSCC patients treated with curative intent at the University of Trieste, Italy from 2015 to 2021. Patients were categorized into 4 groups: (1) tumors classified as T1-T2 by both International Cancer Control (UICC) and American Joint Committee on Cancer (AJCC)-TNM; (2) T1-T2 tumors upgraded to T4 solely by UICC due to oropharyngeal PGM infiltration; (3) T1-T2 tumors upgraded to T4 by both UICC and AJCC due to oral PGM infiltration; (4) tumors classified as T3-T4 by both UICC and AJCC. Kaplan-Meier analysis estimated overall survival (OS) and disease-free survival (DFS). Multivariable Cox models, adjusted for clinical factors, assessed the impact of palatoglossus invasion on outcomes over 5 years.</p><p><strong>Results: </strong>A total of 121 consecutive patients with primary OPSCC were included (median [interquartile range] age 65 years [58-74]; 63% male). While patients with upgraded T4 category due to infiltration of the oral portion of the PGM exhibited a prognosis superimposable on that of other patients with advanced stage disease, those with upgraded T4 category due to infiltration of the oropharyngeal portion of the PGM displayed OS and DFS comparable to T1-T2 patients.</p><p><strong>Conclusion: </strong>Our findings highlight that invasion of the oropharyngeal portion of the PGM may not be a suitable criterion for staging OPSCC as T4. Further research involving larger and independent patient cohorts is strongly encouraged to corroborate these observations.</p>","PeriodicalId":19707,"journal":{"name":"Otolaryngology- Head and Neck Surgery","volume":" ","pages":"1792-1797"},"PeriodicalIF":2.6,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11605017/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142073453","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}